Strategizing from 7 cities across the globe
Transcranial Magnetic Stimulation in the Treatment of Autism Spectrum Disorder
Current attempts at treating ASD primarily involve behavioral analysis and speech therapy, which have only partially alleviated the symptoms without tackling the underlying abnormalities. ASD prevalence has been increasing over the years, where the rate among 5-to-8-year-olds increased by 175% ( from 2.3 per 1000 in 2011 to 6.3 per 1000 in 2022) (Grosvenor et al., 2024). Hence, it has become the focus of intensive research aimed at identifying more efficient treatments. Researchers are proposing transcranial magnetic stimulation (TMS), a non-invasive neuromodulator technique, as a potential treatment for autism due to its success with multiple other neurodevelopmental disorders. TMS has promising results for reducing patients’ symptoms by targeted modulation of the brain’s neural circuits.
PSYCHOLOGYHEALTHCAREMENTAL HEALTHEDUCATIONGENETICSPSYCHIATRYNEUROSCIENCECELLS
Annabel Rizkallah
11/20/20269 min read


Introduction:
For decades, autism spectrum disorder (ASD) has posed a challenge to the scientific community and families alike, a puzzle whose pieces have yet to come together fully. ASD is a complex neurodevelopmental condition characterized by a broad range of symptoms, mainly deficits in social and communication skills, repetitive behavior, and imbalances in excitatory and inhibitory signaling in the brain (Makale et al., 2024). It continues to form barriers between affected individuals and the world, affecting their social relations and reducing the quality of their experiences.
Current attempts at treating ASD primarily involve behavioral analysis and speech therapy, which have only partially alleviated the symptoms without tackling the underlying abnormalities. ASD prevalence has been increasing over the years, where the rate among 5-to-8-year-olds increased by 175% ( from 2.3 per 1000 in 2011 to 6.3 per 1000 in 2022) (Grosvenor et al., 2024). Hence, it has become the focus of intensive research aimed at identifying more efficient treatments. Researchers are proposing transcranial magnetic stimulation (TMS), a non-invasive neuromodulator technique, as a potential treatment for autism due to its success with multiple other neurodevelopmental disorders. TMS has promising results for reducing patients’ symptoms by targeted modulation of the brain’s neural circuits.
Background Information:
According to the DSM-5-TR, autism is defined as a difference in brain functioning that affects how a person communicates and interacts with others. This is evident through avoidance of eye contact, failure of responding to social cues, and a narrow range of interests.
ASD is related to a dysfunctional cingulate gyrus (CG), which is related to controlling attention and cognitive processes (Rowland, 2023, 3). This may impact the attentional switching between cognition and social-emotional neural systems, leading to a difference in emotional processing. Additionally, electroencephalogram (EEG) studies have shown variation in alpha (8-12 Hz) and beta (12.5-30 Hz) frequencies, particularly in the frontal regions of the brain (Rowland, 2023, 4). Due to the involvement of these waves in filtration of information and cognitive processing, they are hypothesized to contribute to this defect in regulation of attention and processing. TMS is explored as a treatment method since it modulates cortical excitability which influences these wave patterns and therefore might prove beneficial in managing the disease (Neo et al., 2023).
TMS is a procedure in which an electromagnetic coil is placed near the scalp of the head, sending an induced current that stimulates neurons in certain areas of the brain, affecting their electrical activity. Currently, TMS is FDA approved for treating depression, OCD, migraines and smoking cessation (Transcranial Magnetic Stimulation - Mayo Clinic, n.d.). TMS can be administered in a repetitive manner (rTMS), or it can include different patterns such as theta-burst stimulation (TBS) in which a triplet of 5 Hz is applied for a total of 15 pulses per second (Transcranial Magnetic Stimulation - Mayo Clinic, n.d.). These types of TMS are low in frequency; however, to treat cases of depression and OCD, deep TMS (dTMS) is used as it has a higher frequency.


Fig.1: Application of Transcranial Magnetic Stimulation. Adapted from: Mayoclinic.org
Research Findings:
In a collaboration between the University of California San Diego, Western University Health Sciences, and Harvard University School of Medicine, researchers conducted an experiment on individuals with ASD using their own adapted version of the conventional rTMS treatment, called the personalized rTMS (PrTMS) (Makale et al., 2024). This treatment is tailored to the participant’s personalized needs based on age, areas of the brain in which the alpha frequency center deviates from normal, and constant feedback from EEGs. Additionally, PrTMS was designed to target a larger area in the brain than conventional rTMS, encompassing the dorsolateral prefrontal cortex, orbitofrontal cortex, medial posterior cortex, and the central motor strip. This treatment was administered 5 days per week over the course of 6-11 weeks, with EEG testing at the beginning of each week. Stimulation intensity was 25–60% of the resting motor threshold, delivered in magnetic pulses of 10–15 second trains with a stimulus frequency of 8–13 Hz (Makale et al., 2024). The efficiency of the PrTMS treatment was assessed by measuring the Autism Spectrum Quotient (ASQ) and Childhood Autism Rating Scale (CARS).
ASQ is a standardized test for autism characteristics often used for adults and adolescents as it is a self-report type of examination, where the higher the score the stronger the autism traits are. Data analysis shows that ASQ scores decreased for all participants, however not all of them registered scores below the cut-off.


Fig.2: The variation in ASQ scores of responding and non responding adult and adolescent patients with respect to the diagnostic cutoff as a function of weeks, p < 0.05. Adapted from: https://doi.org/10.3390/jpm14080857
On the other hand, CARS is a behavioral test for autism symptoms adopted for children who cannot answer the ASQ questionnaire. The severity of ASD is determined by scoring certain behaviors, with a cut-off score of 25 in this study. The results for CARS were similar to those of ASQ: while some patients showed a significant decline in their score to below threshold around week 8, others—although their cases did not exacerbate—showed minimal improvement. The fact that all patients in the study showed a decrease in the prominence of their symptoms is very promising and shows that TMS can be an important tool in treating autism. However, the discrepancies in results between patients raise the question of why the treatment was beneficial for some patients more than others, a sign that much more research is needed before TMS can be put to practice. It should also be noted that the cut-off scores used for the testings were unique to this specific research and differed slightly from standard ones (32 for ASQ and 30 for CARS), which might also affect the results of the experiment.
Case Study: Autism, TMS, and Sleep Spindles:
During sleep, an important type of connection between the thalamus and cortex - called the thalamocortical pathways - plays a crucial role in generating the sleep spindles and slow waves responsible for repairment and memory consolidation. Individuals with ASD have altered pathways, leading to shorter sleep spindle durations (Cebreros-Paniagua et al., 2022) and disrupted coordination between slow waves and sleep spindles in central and frontal regions (Mylonas et al., 2022). From here, researchers across various faculties in the university of UNAM, Ciudad de México, México decided to perform a case study to determine the efficacy of TMS in treating autism by comparing the sleep spindles and slow waves of the individual before and after treatment (Ortiz-Cruz et al., 2024).
The participant in the study was an 11-year-old male diagnosed with ASD according to DSM-V criteria. Two polysomnographic recordings (PSG) on consecutive nights were performed before and after the treatment; the first one was for habituation while the second entailed the electroencephalogram (EEG) recording. The TMS treatment was carried out once per week until 17 sessions were completed in the following manner: the first 6 sessions on right dorsolateral prefrontal cortex (DLPFC), the next 6 sessions on left DLPFC and the last 5 sessions on bilateral DLPFC. The stimulation parameters consisted of 180 pulses of 1 Hz frequency and intensity of 90% of the motor threshold value (Ortiz-Cruz et al., 2024).
The number of sleep spindles and slow waves post treatment increased significantly across the frontal and central EEG channels, where more than half of these waves were generated post TMS.


Fig.3: The total number of spindles and sleep waves before and after TMS treatment for different brain areas. Adapted from: https://doi.org/10.1080/13554794.2024.2436208
These results shed light on a new aspect regarding the benefits of TMS treatment, especially for individuals with ASD, as they show improvement in the thalamocortical pathways, and thus, better sleep quality as well as enhanced semantic memory. Being the only study to have investigated this subject, its results cannot be considered conclusive, making it an interesting point for future research.
Limitations and Concerns:
Despite its potential as a treatment for ASD, TMS is a relatively new therapeutic technique with several limitations that prevent its clinical application. One major drawback is the absence of longitudinal studies that clarify whether it may have any negative side effects in the long run. Although it is FDA approved for use in treating various conditions such as depression and smoking addiction, its use for ASD treatment remains tentative. It raises the question of safety and whether potential complications that might arise in the future are taken into consideration for this approval. This rapid translation of experimental research into clinical practice has prompted significant concern and uncertainty among many, especially when it comes to sensitive cases such as ASD.
Moreover, the effects of TMS are not permanent, ranging between months and years on a case-to-case basis, which means that there must be a follow-up treatment every now and then to re-establish the reduction of symptoms. Being non-invasive, this is not much of a disturbance to the patient. However, it is not the ideal one-time treatment that scientists aspire to achieve. Additionally, the TMS waves cannot exceed 2-4 cm of depth into the brain - a maximum of 6cm
for deep TMS (Ferrulli et al., 2020). Hence, TMS is able to target superficial regions of the brain only, which is particularly relevant to ASD because the disorder involves complex alterations across multiple neural circuits that may not be accessible through this technique. While scientists are working on a way to solve this problem and manipulate the waves in a way that can stimulate the brain in a deeper and more effective manner, there have been no successful breakthroughs so far in this domain leading to another setback for this type of treatment.
The fact that autism is a spectrum disease affecting different parts of the brain in each individual might also make it more challenging to treat with TMS. Therefore, a stimulation protocol may not produce the same effects in different patients. This has directed interest to development of personalized approaches to TMS, which target the neural circuits most relevant
to each individual’s symptoms. However, because TMS can influence a broader area than the one being targeted, further research is required to determine whether repeated stimulation may cause negative consequences on other brain regions.
Studies investigating TMS in individuals with ASD involve relatively small sample sizes, limiting the statistical power and generalizability of their findings. These results should not be disregarded, but rather built upon with larger, well-controlled, and long-term studies before TMS can be confidently established as a standard treatment for ASD.
These limitations don’t undermine the therapeutic potential of TMS; instead, they highlight the need for more extensive studies to further improve the utility of this technique. At the same time, with the great advancements in genetic and molecular biology, researchers might make use of alternative technologies like gene editing to complement or even surpass TMS.
Conclusion:
TMS has shown important success in treating a myriad of neurological conditions, and scientists have hopes of achieving the same results for ASD. The current research findings are promising, but it is too early to draw definitive conclusions about its long term efficacy. After all, ASD is one of the most complex conditions in medicine, with new discoveries adding bits and pieces to our knowledge. The puzzle is far from complete—but could TMS represent one of its missing pieces?
Download the full Document
Refrences:
Cebreros-Paniagua, R., Ayala-Guerrero, F., Mateos-Salgado, E. L., Villamar-Flores, C. I., Gutiérrez Chávez, C. A., & Jiménez-Correa, U. (2022). Analysis of sleep spindles in children with Asperger’s syndrome. DOAJ (DOAJ: Directory of Open Access Journals), 14(3), 201–206. https://doi.org/10.5935/1984-0063.20200059
Ferrulli, A., Massarini, S., Macrì, C., & Luzi, L. (2020). Safety and tolerability of repeated sessions of deep transcranial magnetic stimulation in obesity. Endocrine, 71(2), 331–343. https://doi.org/10.1007/s12020-020-02496-x
Grosvenor, L. P., Croen, L. A., Lynch, F. L., Marafino, B. J., Maye, M., Penfold, R. B., Simon, G. E., & Ames, J. L. (2024). Autism diagnosis among US children and adults, 2011-2022. JAMA Network Open, 7(10), e2442218.
https://doi.org/10.1001/jamanetworkopen.2024.42218
Makale, M. T., Nybo, C., Blum, K., Dennen, C. A., Elman, I., & Murphy, K. T. (2024). Pilot Study of Personalized Transcranial Magnetic Stimulation with Spectral
Electroencephalogram Analyses for Assessing and Treating Persons with Autism. Journal of Personalized Medicine, 14(8), 857. https://doi.org/10.3390/jpm14080857
Mylonas, D., Sjøgård, M., Shi, Z., Baxter, B., Hämäläinen, M., Manoach, D. S., & Khan, S. (2022). A novel approach to estimating the cortical sources of sleep spindles using simultaneous EEG/MEG. Frontiers in Neurology, 13.
https://doi.org/10.3389/fneur.2022.871166
Neo, W. S., Foti, D., Keehn, B., & Kelleher, B. (2023). Resting-state EEG power differences in autism spectrum disorder: a systematic review and meta-analysis. Translational Psychiatry, 13(1), 389. https://doi.org/10.1038/s41398-023-02681-2
Ortiz-Cruz, E. E., Ayala-Guerrero, F., Mateos-Salgado, E. L., Bernal-Hernández, J., Carillo-Calvet, H. A., & Jiménez-Andrade, J. L. (2024b). Artificial neural network for evaluating sleep spindles and slow waves after trans-cranial magnetic stimulation in a child with autism. Neurocase, 1–9. https://doi.org/10.1080/13554794.2024.2436208
Rowland, D. (2023). Neurophysiology is what makes the Autistic Brain Different. Journal of Neurology Psychiatry and Brain Research, 4. ResearchGate.
https://www.researchgate.net/publication/377148401_Neurophysiology_is_what_makes_ the_Autistic_Brain_Different
Transcranial magnetic stimulation - Mayo Clinic. (n.d.).
https://www.mayoclinic.org/tests-procedures/transcranial-magnetic-stimulation/about/pac -20384625
